Vitiligo: An Evidence-Based Update. Report of the 13th Evidence-Based Update Meeting, 23 May 2013, Loughborough, UK
October 2013
in “
British Journal of Dermatology
”
New to Calcipotriene? There is a guide in the encyclopedia. Read the guide → vitiligo nonsegmental vitiligo segmental vitiligo autoimmune factors topical steroids calcipotriol UV radiation excimer lasers tissue grafting cellular grafting home phototherapy topical corticosteroids calcineurin inhibitors phototherapy UV light laser treatment steroid creams topical immunosuppressants
Studysummary This meeting report provides an overview of recent evidence on vitiligo treatments, indicating a lack of standardized outcome measures and emphasizing the need for more consistent clinical trials.
Our plain-language summary. Not medical advice or a treatment recommendation. Consult a qualified healthcare professional before changing treatment. Full disclaimer
The 13th Evidence Based Update Meeting on vitiligo, held on May 23, 2013, in Loughborough, U.K., reviewed the latest research on vitiligo classification, treatment options, and guidelines. Key points included the classification of vitiligo into nonsegmental (NSV) and segmental (SV) types, with NSV linked to autoimmune factors. Effective treatments discussed were topical steroids, calcipotriol, UV radiation, and excimer lasers, especially when combined with topical steroids. Surgical treatments like tissue and cellular grafting were effective for stable lesions. A pilot study on home phototherapy showed patient willingness and potential efficacy. The European Dermatology Forum guidelines recommended topical corticosteroids, calcineurin inhibitors, and phototherapy, stressing the need for standardized research methods and long-term safety data. The meeting concluded with optimism about the increasing research interest in vitiligo and its management.
